ArticleNature communications2026
PE/PPE proteins contribute to Mycobacterium tuberculosis drug resistance.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Variation in multiple classes of simple sequence repeats can alter drug susceptibility inbioRxiv : the preprint server for biology · 2026Article
Corrections and comments
- Update of
Authors and funding
5 authors.
Funding
Abstract
The mycobacterial outer membrane (OM) creates a formidable permeability barrier, and whether drugs traverse it by mechanisms other than passive diffusion remains unclear. The proline-glutamic acid (PE) and proline-proline-glutamic acid (PPE) proteins of pathogenic mycobacteria include several OM transporters. Because bacterial transporters are also major contributors to drug resistance, we tested the role of PE/PPE proteins in Mycobacterium tuberculosis (Mtb) drug susceptibility. We identified mutations in multiple pe/ppe genes that were strongly associated with drug resistance in a genetic association study. A mutation in ppe42 linked to clinical amikacin resistance also conferred higher amikacin resistance in vitro. Deletion of ppe51 led to in vitro resistance to multiple drugs and was accompanied by upregulation of inner membrane efflux pumps. Deletion of a pe/ppe pair that responded transcriptionally to drug exposure, pe25/ppe41, led to increased resistance to isoniazid (INH) in strains across all major Mtb lineages and accelerated the emergence of INH resistance in vitro. These data show a role of several Mtb PE/PPE proteins in drug resistance consistent with the PE/PPE transporter paradigm and suggest a wider role of the PE/PPE family in Mtb drug susceptibility and clinical drug resistance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.